- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.01 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x NAG- GAL- SIA: N-acetyl-alpha-neuraminic acid-(2-3)-beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x LWL: N,N,N-trimethyl-2-oxo-2-(2-(pyridin-2-ylmethylene)hydrazineyl)ethan-1-aminium(Non-covalent)
LWL.5: 12 residues within 4Å:- Chain A: W.86, G.121, G.122, Y.124, E.202, S.203, W.236, V.294, Y.337, F.338, H.447
- Ligands: ZN.6
9 PLIP interactions:9 interactions with chain A- Hydrophobic interactions: A:W.236, A:V.294, A:F.338
- Hydrogen bonds: A:G.122, A:Y.124
- Water bridges: A:Y.337
- Salt bridges: A:E.202
- pi-Cation interactions: A:W.86, A:W.86
LWL.42: 12 residues within 4Å:- Chain B: W.86, G.121, G.122, Y.124, E.202, S.203, W.236, V.294, Y.337, F.338, H.447
- Ligands: ZN.43
7 PLIP interactions:7 interactions with chain B- Hydrophobic interactions: B:W.236, B:V.294, B:F.338
- Hydrogen bonds: B:Y.124
- Salt bridges: B:E.202
- pi-Cation interactions: B:W.86, B:W.86
- 4 x ZN: ZINC ION(Non-covalent)
ZN.6: 3 residues within 4Å:- Chain A: S.203, H.447
- Ligands: LWL.5
2 PLIP interactions:2 interactions with chain A- Metal complexes: A:S.203, A:H.447
ZN.35: 3 residues within 4Å:- Chain A: H.381
- Chain B: H.381
- Ligands: CL.63
2 PLIP interactions:1 interactions with chain A, 1 interactions with chain B- Metal complexes: A:H.381, B:H.381
ZN.36: 3 residues within 4Å:- Chain A: H.287
- Ligands: CL.23, CL.26
2 PLIP interactions:1 interactions with chain A, 1 Ligand-Water interactions- Metal complexes: A:H.287, H2O.3
ZN.43: 3 residues within 4Å:- Chain B: S.203, H.447
- Ligands: LWL.42
2 PLIP interactions:2 interactions with chain B- Metal complexes: B:S.203, B:H.447
- 21 x SO4: SULFATE ION(Non-functional Binders)
SO4.7: 3 residues within 4Å:- Chain A: Q.413, R.417, N.533
Ligand excluded by PLIPSO4.8: 3 residues within 4Å:- Chain A: R.356, L.360
- Chain B: R.534
Ligand excluded by PLIPSO4.9: 3 residues within 4Å:- Chain A: T.504, G.506, A.507
Ligand excluded by PLIPSO4.10: 1 residues within 4Å:- Chain A: H.322
Ligand excluded by PLIPSO4.11: 4 residues within 4Å:- Chain A: G.240, M.241, G.242
- Ligands: CL.32
Ligand excluded by PLIPSO4.12: 2 residues within 4Å:- Chain A: F.80, K.348
Ligand excluded by PLIPSO4.13: 1 residues within 4Å:- Chain A: R.90
Ligand excluded by PLIPSO4.14: 4 residues within 4Å:- Chain A: P.108, T.109, S.110, R.143
Ligand excluded by PLIPSO4.15: 3 residues within 4Å:- Chain A: V.520, R.521, R.522
Ligand excluded by PLIPSO4.16: 2 residues within 4Å:- Chain A: N.317, R.417
Ligand excluded by PLIPSO4.17: 5 residues within 4Å:- Chain A: H.387, P.388, E.389, D.390
- Ligands: MG.37
Ligand excluded by PLIPSO4.44: 4 residues within 4Å:- Chain B: R.475, Y.479, E.491, A.497
Ligand excluded by PLIPSO4.45: 4 residues within 4Å:- Chain B: T.504, A.505, G.506, A.507
Ligand excluded by PLIPSO4.46: 2 residues within 4Å:- Chain B: R.90, E.91
Ligand excluded by PLIPSO4.47: 1 residues within 4Å:- Chain B: R.478
Ligand excluded by PLIPSO4.48: 3 residues within 4Å:- Chain B: R.16, S.57, G.58
Ligand excluded by PLIPSO4.49: 3 residues within 4Å:- Chain B: Q.413, R.417, N.533
Ligand excluded by PLIPSO4.50: 3 residues within 4Å:- Chain B: T.466, A.467, E.468
Ligand excluded by PLIPSO4.51: 1 residues within 4Å:- Chain B: R.136
Ligand excluded by PLIPSO4.52: 4 residues within 4Å:- Chain A: R.534
- Chain B: R.356, L.360, W.385
Ligand excluded by PLIPSO4.53: 4 residues within 4Å:- Chain B: P.108, T.109, S.110, R.143
Ligand excluded by PLIP- 36 x CL: CHLORIDE ION(Non-functional Binders)
CL.18: 1 residues within 4Å:- Chain A: A.467
Ligand excluded by PLIPCL.19: 2 residues within 4Å:- Chain A: R.177, Q.181
Ligand excluded by PLIPCL.20: 2 residues within 4Å:- Chain A: R.16, G.58
Ligand excluded by PLIPCL.21: 2 residues within 4Å:- Chain A: S.371, D.372
Ligand excluded by PLIPCL.22: 3 residues within 4Å:- Chain A: N.233, P.312, E.313
Ligand excluded by PLIPCL.23: 3 residues within 4Å:- Chain A: N.283, H.287
- Ligands: ZN.36
Ligand excluded by PLIPCL.24: 1 residues within 4Å:- Chain A: T.195
Ligand excluded by PLIPCL.25: 1 residues within 4Å:- Chain A: R.136
Ligand excluded by PLIPCL.26: 2 residues within 4Å:- Chain A: W.286
- Ligands: ZN.36
Ligand excluded by PLIPCL.27: 3 residues within 4Å:- Chain A: R.525, A.526, Q.527
Ligand excluded by PLIPCL.28: 3 residues within 4Å:- Chain A: R.13, E.185, N.186
Ligand excluded by PLIPCL.29: 1 residues within 4Å:- Chain A: R.424
Ligand excluded by PLIPCL.30: 2 residues within 4Å:- Chain A: G.240, R.296
Ligand excluded by PLIPCL.31: 3 residues within 4Å:- Chain A: H.387, R.393
- Ligands: MG.37
Ligand excluded by PLIPCL.32: 2 residues within 4Å:- Chain A: R.246
- Ligands: SO4.11
Ligand excluded by PLIPCL.33: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPCL.34: 2 residues within 4Å:- Chain A: N.283, H.284
Ligand excluded by PLIPCL.54: 6 residues within 4Å:- Chain A: L.386
- Chain B: G.523, R.525, A.526, Q.527
- Ligands: MG.73
Ligand excluded by PLIPCL.55: 1 residues within 4Å:- Chain B: R.393
Ligand excluded by PLIPCL.56: 1 residues within 4Å:- Chain B: R.525
Ligand excluded by PLIPCL.57: 3 residues within 4Å:- Chain B: H.387, E.389, D.390
Ligand excluded by PLIPCL.58: 2 residues within 4Å:- Chain B: R.219, L.324
Ligand excluded by PLIPCL.59: 1 residues within 4Å:- Chain B: L.441
Ligand excluded by PLIPCL.60: 1 residues within 4Å:- Chain B: P.36
Ligand excluded by PLIPCL.61: 1 residues within 4Å:- Chain B: P.44
Ligand excluded by PLIPCL.62: 4 residues within 4Å:- Chain B: G.264, N.265, D.266, T.267
Ligand excluded by PLIPCL.63: 3 residues within 4Å:- Chain A: H.381
- Chain B: H.381
- Ligands: ZN.35
Ligand excluded by PLIPCL.64: 4 residues within 4Å:- Chain B: Y.70, S.93, E.94
- Ligands: MG.79
Ligand excluded by PLIPCL.65: 2 residues within 4Å:- Chain B: S.371, D.372
Ligand excluded by PLIPCL.66: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPCL.67: 1 residues within 4Å:- Chain B: H.322
Ligand excluded by PLIPCL.68: 2 residues within 4Å:- Chain B: R.246
- Ligands: MG.75
Ligand excluded by PLIPCL.69: 2 residues within 4Å:- Chain B: R.521, R.522
Ligand excluded by PLIPCL.70: 2 residues within 4Å:- Chain B: P.312, E.313
Ligand excluded by PLIPCL.71: 2 residues within 4Å:- Chain B: Q.66
- Ligands: MG.74
Ligand excluded by PLIPCL.72: 3 residues within 4Å:- Chain B: M.241, G.242
- Ligands: MG.75
Ligand excluded by PLIP- 12 x MG: MAGNESIUM ION(Non-covalent)(Non-functional Binders)
MG.37: 5 residues within 4Å:- Chain A: H.387, D.390, R.393
- Ligands: SO4.17, CL.31
No protein-ligand interaction detected (PLIP)MG.38: 2 residues within 4Å:- Chain A: H.387
- Chain B: R.522
No protein-ligand interaction detected (PLIP)MG.39: 1 residues within 4Å:- Chain A: H.253
No protein-ligand interaction detected (PLIP)MG.40: 0 residues within 4Å:- (No contacts)
No protein-ligand interaction detected (PLIP)MG.41: 1 residues within 4Å:- Chain A: H.284
3 PLIP interactions:1 interactions with chain A, 2 Ligand-Water interactions- Metal complexes: A:H.284, H2O.3, H2O.3
MG.73: 5 residues within 4Å:- Chain B: R.525, A.526, Q.527, A.528
- Ligands: CL.54
No protein-ligand interaction detected (PLIP)MG.74: 2 residues within 4Å:- Chain B: Q.66
- Ligands: CL.71
No protein-ligand interaction detected (PLIP)MG.75: 5 residues within 4Å:- Chain B: G.240, G.242, E.243
- Ligands: CL.68, CL.72
No protein-ligand interaction detected (PLIP)MG.76: 2 residues within 4Å:- Chain B: P.162, R.245
No protein-ligand interaction detected (PLIP)MG.77: 1 residues within 4Å:- Chain B: H.284
1 PLIP interactions:1 interactions with chain B- Metal complexes: B:H.284
MG.78: 1 residues within 4Å:- Chain B: H.253
3 PLIP interactions:1 interactions with chain B, 2 Ligand-Water interactions- Metal complexes: B:H.253, H2O.5, H2O.5
MG.79: 2 residues within 4Å:- Chain B: S.93
- Ligands: CL.64
No protein-ligand interaction detected (PLIP)- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Nachon, F. et al., Grid-Type Quaternary Metallosupramolecular Compounds Inhibit Human Cholinesterases through Dynamic Multivalent Interactions. Chembiochem (2022)
- Release Date
- 2023-06-21
- Peptides
- Acetylcholinesterase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.01 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x NAG- GAL- SIA: N-acetyl-alpha-neuraminic acid-(2-3)-beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x LWL: N,N,N-trimethyl-2-oxo-2-(2-(pyridin-2-ylmethylene)hydrazineyl)ethan-1-aminium(Non-covalent)
- 4 x ZN: ZINC ION(Non-covalent)
- 21 x SO4: SULFATE ION(Non-functional Binders)
- 36 x CL: CHLORIDE ION(Non-functional Binders)
- 12 x MG: MAGNESIUM ION(Non-covalent)(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Nachon, F. et al., Grid-Type Quaternary Metallosupramolecular Compounds Inhibit Human Cholinesterases through Dynamic Multivalent Interactions. Chembiochem (2022)
- Release Date
- 2023-06-21
- Peptides
- Acetylcholinesterase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B